Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,402Revenue $M1,117Net Margin (%)23.4Z-Score7.1
Enterprise Value $M6,197EPS $3.3Operating Margin %38.9F-Score6
P/E(ttm))26.3Cash Flow Per Share $4.9Pre-tax Margin (%)37.9Higher ROA y-yN
Price/Book5.410-y EBITDA Growth Rate %0Quick Ratio1.3Cash flow > EarningsY
Price/Sales6.15-y EBITDA Growth Rate %0Current Ratio1.3Lower Leverage y-yY
Price/Cash Flow10.6y-y EBITDA Growth Rate %-1.3ROA % (ttm)14.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)22.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M48.2ROI % (ttm)20.2Gross Margin Increase y-yY

Gurus Latest Trades with UTHR

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
UTHRJoel Greenblatt 2014-06-30 Add0.37%$86.14 - $107.81
($96.29)
$ 132.3938%Add 104.14%646,066
UTHRJoel Greenblatt 2014-03-31 Add0.17%$90.67 - $113.39
($102.75)
$ 132.3929%Add 62.64%316,489
UTHRJohn Hussman 2013-12-31 Reduce-1%$80.03 - $114.51
($89.93)
$ 132.3947%Reduce -62.57%134,000
UTHRJoel Greenblatt 2013-12-31 Reduce-0.45%$80.03 - $114.51
($89.93)
$ 132.3947%Reduce -47.71%194,595
UTHRJohn Hussman 2013-09-30 Reduce-0.33%$66.1 - $79.58
($73.08)
$ 132.3981%Reduce -23.5%358,000
UTHRVanguard Health Care Fund 2013-09-30 Sold Out -0.32%$66.1 - $79.58
($73.08)
$ 132.3981%Sold Out0
UTHRDavid Dreman 2013-09-30 Sold Out -0.12%$66.1 - $79.58
($73.08)
$ 132.3981%Sold Out0
UTHRJoel Greenblatt 2013-06-30 Add0.13%$59.64 - $69.31
($64.42)
$ 132.39106%Add 15.34%341,330
UTHRDavid Dreman 2012-12-31 Buy 0.09%$44.99 - $58.91
($52.11)
$ 132.39154%New holding, 57025 sh.57,025
UTHRJohn Hussman 2012-09-30 Buy 0.67%$49.73 - $58.2
($54.16)
$ 132.39144%New holding, 500000 sh.500,000
UTHRJoel Greenblatt 2012-06-30 Add0.6%$41.19 - $49.51
($44.12)
$ 132.39200%Add 101.59%332,744
UTHRRichard Perry 2012-06-30 Sold Out -0.04%$41.19 - $49.51
($44.12)
$ 132.39200%Sold Out0
UTHRJoel Greenblatt 2012-03-31 Add0.31%$45.54 - $50.99
($45.17)
$ 132.39193%Add 82.68%165,063
UTHRRichard Perry 2012-03-31 Buy 0.04%$45.54 - $50.99
($45.17)
$ 132.39193%New holding, 15300 sh.15,300
UTHRJoel Greenblatt 2011-12-31 Add0.15%$37.21 - $47.54
($41.57)
$ 132.39218%Add 38.75%90,355
UTHRJoel Greenblatt 2011-09-30 Add0.29%$37.47 - $57.38
($48.47)
$ 132.39173%Add 274.82%65,122
UTHRVanguard Health Care Fund 2011-09-30 Add0.16%$37.47 - $57.38
($48.47)
$ 132.39173%Add 77.9%1,787,000
UTHRMichael Price 2011-09-30 Sold Out -0.1%$37.47 - $57.38
($48.47)
$ 132.39173%Sold Out0
UTHRGeorge Soros 2011-09-30 Sold Out -0.0776%$37.47 - $57.38
($48.47)
$ 132.39173%Sold Out0
UTHRVanguard Health Care Fund 2011-06-30 Add0.18%$53.49 - $70.7
($63.39)
$ 132.39109%Add 183.36%1,004,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

UTHR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
UTHR Joel Greenblatt 2014-06-30646,0661.340.72+104.14%
UTHR John Hussman 2014-06-30134,0000.280.91
Premium Most recent portfolio changes are included for Premium Members only!


UTHR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
JEFFS ROGERPresident & COO 2014-09-19Sell10,000$129.6-0.9view
ROTHBLATT MARTINE ACEO 2014-09-18Sell9,662$127.350.86view
Ferrari John MaximCFO 2014-09-18Sell10,000$130.93-1.9view
JEFFS ROGERPresident & COO 2014-09-17Sell20,000$127.011.13view
ROTHBLATT MARTINE ACEO 2014-09-15Sell50,000$124.523.15view
ROTHBLATT MARTINE ACEO 2014-09-11Sell9,662$120.796.33view
MAHON PAUL AEVP & General Counsel 2014-09-11Sell5,000$120.76.41view
Giltner RichardDirector 2014-09-10Sell20,000$119.957.08view
ROTHBLATT MARTINE ACEO 2014-09-10Sell50,000$120.017.02view
JEFFS ROGERPresident & COO 2014-09-09Sell20,676$117.189.61view

Press Releases about UTHR :

    Quarterly/Annual Reports about UTHR:

    News about UTHR:

    Articles On GuruFocus.com
    Here are 5 Good Companies to Consider Investing In Right Now Feb 11 2014 
    High-Dollar Insider Sells - Zuckerberg Sells 41M Facebook Shares Dec 27 2013 
    John Hussman's Third Quarter Top 5 Nov 07 2013 
    Vanguard Health Care Fund Selling Update Oct 30 2013 
    comment on UTHR May 11 2013 
    Super-Fast Growing Mid-Cap Growth Stocks with Explosive Returns May 09 2013 
    5 Fast-Growing Small-Cap Stocks to Watch Mar 26 2013 
    comment on UTHR Mar 23 2013 
    fd Jan 12 2013 
    bmn Jan 12 2013 

    More From Our Partners
    Axsome Therapeutics Announces Appointments to Its Board of Directors Sep 17 2014 - BENZINGA

    More From Other Websites
    Axsome Therapeutics Announces Appointments to Its Board of Directors Sep 17 2014
    Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market Sep 16 2014
    Today's Thorns, Roses, and All Time Highs... Sep 15 2014
    Pluristem & United Therapeutics Progress with Phase I Study Sep 09 2014
    United Therapeutics Soars on Remodulin Patent Case Win Sep 02 2014
    United Therapeutics (UTHR) Shares March Higher, Can It Continue? Sep 02 2014
    United Therapeutics Legal Victory Sends Stock Flying Aug 29 2014
    United Therapeutics Up 27% as Patent Win 'Close to a Best Case Scenario' Aug 29 2014
    United Therapeutics rises on drug-patent ruling Aug 29 2014
    United Therapeutics rises on drug-patent ruling Aug 29 2014
    District Court Decision Received In Remodulin Patent Case Aug 29 2014
    Catalyst Pharmaceutical Partners (CPRX) Worth Watching: Stock Up 10.3% Aug 26 2014
    Roche Buying InterMune for $8.3 Billion; Investors Want More Pharma Deals Aug 25 2014
    Can United Therapeutics (UTHR) Keep the Earnings Streak Alive This Quarter? Aug 20 2014
    UNITED THERAPEUTICS CORP Financials Aug 02 2014
    United Therapeutics (UTHR) Up on Q2 Earnings & Revenue Beat Jul 31 2014
    Perilous Reversal Watch: United Therapeutics (UTHR) Jul 30 2014
    United Therapeutics (UTHR) Jumps: Stock Adds 8.1% in Session Jul 30 2014
    Q2 2014 United Therapeutics Earnings Release - Before Market Open Jul 29 2014
    UNITED THERAPEUTICS CORP Files SEC form 8-K, Results of Operations and Financial Condition Jul 29 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK